• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助放化疗后直肠癌经肛门局部切除:它有存在的价值还是应不惜一切代价避免?

Transanal Local Excision of Rectal Cancer after Neoadjuvant Chemoradiation: Is There a Place for It or Should Be Avoided at All Costs?

作者信息

Perez Rodrigo Oliva, Julião Guilherme Pagin São, Vailati Bruna Borba

机构信息

Department of Surgical Oncology, Hospital Beneficencia Portuguesa, São Paulo, Brazil.

Division of Colorectal Surgery, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.

出版信息

Clin Colon Rectal Surg. 2022 Feb 28;35(2):122-128. doi: 10.1055/s-0041-1742112. eCollection 2022 Mar.

DOI:10.1055/s-0041-1742112
PMID:35237107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8885162/
Abstract

Tumor response to neoadjuvant chemoradiation (nCRT) with tumor downsizing and downstaging has significantly impacted the number of patients considered to be appropriate candidates for transanal local excision (TLE). Some patients may harbor small residual lesions, restricted to the bowel wall. These patients, who exhibit major response ("near-complete") by digital rectal examination, endoscopic assessment, and radiological assessment may be considered for this approach. Although TLE is associated with minimal postoperative morbidity, a few clinical consequences and oncological outcomes must be evaluated in advance and with caution. In the setting of nCRT, a higher risk for clinically relevant wound dehiscences leading to a considerable risk for readmission for pain management has been observed. Worse anorectal function (still better than after total mesorectal excision [TME]), worsening in the quality of TME specimen, and higher rates of abdominal resections (in cases requiring completion TME) have been reported. The exuberant scar observed in the area of TLE also represents a challenging finding during follow-up of these patients. Local excision should be probably restricted for patients with primary tumors located at or below the level of the anorectal ring (magnetic resonance defined). These patients are otherwise candidates for abdominal perineal resections or ultra-low anterior resections with coloanal anastomosis frequently requiring definitive stomas or considerably poor anorectal function.

摘要

肿瘤对新辅助放化疗(nCRT)的反应,包括肿瘤缩小和降期,显著影响了被认为适合行经肛门局部切除(TLE)的患者数量。一些患者可能存在局限于肠壁的小残留病灶。通过直肠指检、内镜评估和影像学评估显示有主要反应(“近乎完全”)的这些患者,可考虑采用这种方法。尽管TLE术后发病率极低,但仍需提前谨慎评估一些临床后果和肿瘤学结局。在nCRT的情况下,已观察到临床相关伤口裂开的风险较高,这导致因疼痛管理而再次入院的风险相当大。据报道,肛门直肠功能较差(仍优于全直肠系膜切除术后[TME]),TME标本质量恶化,腹部切除术发生率较高(在需要完成TME的病例中)。在TLE区域观察到的增生性瘢痕在这些患者的随访中也是一个具有挑战性的发现。局部切除可能应仅限于原发性肿瘤位于肛门直肠环(磁共振定义)或其以下水平的患者。否则,这些患者是腹会阴切除术或低位前切除术加结肠肛管吻合术的候选者,这些手术常常需要永久性造口或肛门直肠功能相当差。

相似文献

1
Transanal Local Excision of Rectal Cancer after Neoadjuvant Chemoradiation: Is There a Place for It or Should Be Avoided at All Costs?新辅助放化疗后直肠癌经肛门局部切除:它有存在的价值还是应不惜一切代价避免?
Clin Colon Rectal Surg. 2022 Feb 28;35(2):122-128. doi: 10.1055/s-0041-1742112. eCollection 2022 Mar.
2
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.新辅助放化疗后残留直肠癌(ypT0-2)经肛门内镜微创手术:另需谨慎。
Dis Colon Rectum. 2013 Jan;56(1):6-13. doi: 10.1097/DCR.0b013e318273f56f.
3
Comparison of transanal total mesorectal excision and robotic total mesorectal excision for low rectal cancer after neoadjuvant chemoradiotherapy.新辅助放化疗后经肛门全直肠系膜切除术与机器人辅助全直肠系膜切除术治疗低位直肠癌的比较
Surg Endosc. 2021 Dec;35(12):6998-7004. doi: 10.1007/s00464-020-08213-z. Epub 2021 Feb 1.
4
[Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].新辅助放化疗后直肠癌局部切除的预后及并发症
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Apr 25;24(4):344-351. doi: 10.3760/cma.j.cn.441530-20201204-00644.
5
[Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].巩固性新辅助治疗或全新辅助治疗后低位直肠癌的保直肠手术:初步报告
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Mar 25;23(3):281-288. doi: 10.3760/cma.j.cn.441530-20200228-00096.
6
Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.新辅助放化疗后保肛策略对低位直肠癌患者肛门直肠功能的影响
Dis Colon Rectum. 2016 Apr;59(4):264-9. doi: 10.1097/DCR.0000000000000543.
7
Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?经肛门局部切除术治疗低位直肠癌和新辅助放化疗不完全缓解——基线分期是否重要?
Dis Colon Rectum. 2014 Nov;57(11):1253-9. doi: 10.1097/DCR.0000000000000215.
8
Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.术前放化疗后局部切除治疗ypT0 直肠癌的长期疗效。
Dis Colon Rectum. 2014 Nov;57(11):1245-52. doi: 10.1097/DCR.0000000000000221.
9
Laparoscopic transanal abdominal transanal resection with sphincter preservation for rectal cancer in the distal 3 cm of the rectum after neoadjuvant therapy.经新辅助治疗后直肠下段 3cm 以内直肠癌的腹腔镜经肛腹部经肛直肠切除术并保肛。
Surg Endosc. 2010 Nov;24(11):2700-7. doi: 10.1007/s00464-010-1028-8. Epub 2010 Apr 23.
10
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.经术前放化疗后 ypT0-1 期直肠腺癌患者行经肛门内镜微创手术与全直肠系膜切除术的对比:术后并发症、功能结果和长期肿瘤学转归。
Dis Colon Rectum. 2022 Nov 1;65(11):1306-1315. doi: 10.1097/DCR.0000000000002255. Epub 2022 Jan 20.

引用本文的文献

1
Nonoperative management of rectal cancer.直肠癌的非手术治疗
Front Oncol. 2024 Dec 6;14:1477510. doi: 10.3389/fonc.2024.1477510. eCollection 2024.
2
Lymph node metastasis following chemoradiotherapy in advanced rectal cancer: ypT2-focused analyses of total mesorectal excision specimens.晚期直肠癌放化疗后的淋巴结转移:全直肠系膜切除标本的ypT2重点分析
Tech Coloproctol. 2024 Dec 11;29(1):15. doi: 10.1007/s10151-024-03046-7.
3
Survival prognostic in different age groups of patients undergoing local versus radical excision for rectal cancer: a study based on the SEER database.基于 SEER 数据库的研究:局部切除术与根治性切除术治疗直肠癌患者不同年龄组的生存预后比较。
Updates Surg. 2024 Jun;76(3):975-988. doi: 10.1007/s13304-024-01846-y. Epub 2024 May 5.
4
Pattern of Residual Submucosal Involvement after Neoadjuvant Therapy for Rectal Cancer: A Rationale for the Utility of Endoscopic Submucosal Resection.直肠癌新辅助治疗后残留黏膜下浸润的模式:内镜黏膜下剥离术实用性的依据。
Medicina (Kaunas). 2023 Oct 11;59(10):1807. doi: 10.3390/medicina59101807.
5
The Role of Local Excision after Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Different Perspective.新辅助治疗后局部切除在局部进展期直肠癌中的作用:一个不同的视角。
Clin Colon Rectal Surg. 2022 Nov 29;36(4):290-294. doi: 10.1055/s-0042-1758808. eCollection 2023 Jul.
6
Association between microsatellite instability and tumor response to neoadjuvant chemoradiotherapy for rectal cancer.微卫星不稳定性与直肠癌新辅助放化疗的肿瘤反应之间的关联。
Ann Surg Treat Res. 2022 Sep;103(3):176-182. doi: 10.4174/astr.2022.103.3.176. Epub 2022 Sep 6.
7
Role of Local Excision for Suspected Regrowth in a Watch and Wait Strategy for Rectal Cancer.局部切除在直肠癌观察等待策略中对疑似复发的作用。
Cancers (Basel). 2022 Jun 23;14(13):3071. doi: 10.3390/cancers14133071.

本文引用的文献

1
Completion Surgery in Unfavorable Rectal Cancer after Transanal Endoscopic Microsurgery: Does It Achieve Satisfactory Sphincter Preservation, Quality of Total Mesorectal Excision Specimen, and Long-term Oncological Outcomes?经肛门内镜微创手术(TEM)后行补救性手术治疗不利直肠癌:是否能够达到满意的肛门括约肌保留效果、全直肠系膜切除标本质量以及长期肿瘤学结局?
Dis Colon Rectum. 2021 Feb 1;64(2):200-208. doi: 10.1097/DCR.0000000000001730.
2
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.根治性手术与短程放疗联合经肛门内镜微创手术保肛治疗早期直肠癌(TREC):一项随机、开放标签可行性研究。
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):92-105. doi: 10.1016/S2468-1253(20)30333-2. Epub 2020 Dec 11.
3
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.直肠癌的放化疗联合局部切除保肛治疗:GRECCAR 2 随机试验的 5 年结果。
Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7.
4
Systematic review of functional outcomes and quality of life after transanal endoscopic microsurgery and transanal minimally invasive surgery: a word of caution.经肛门内镜微创手术和经肛门微创手术后功能结局和生活质量的系统评价:谨慎之词。
Int J Colorectal Dis. 2020 Jan;35(1):51-67. doi: 10.1007/s00384-019-03439-3. Epub 2019 Nov 25.
5
Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer.磁共振成像在直肠癌患者保器官治疗策略中的作用
Insights Imaging. 2019 May 30;10(1):59. doi: 10.1186/s13244-019-0742-6.
6
For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection?对于早期直肠癌患者,局部切除相对于根治性切除对复发、生存和生活质量有影响吗?
Ann Surg Oncol. 2019 Aug;26(8):2497-2506. doi: 10.1245/s10434-019-07328-5. Epub 2019 Apr 25.
7
Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis.经肛门全直肠系膜切除(cTaTME)治疗直肠癌的短期疗效:病例匹配分析。
Surg Endosc. 2019 Jan;33(1):103-109. doi: 10.1007/s00464-018-6280-3. Epub 2018 Jul 2.
8
Should the rectal defect be closed following transanal local excision of rectal tumors? A systematic review and meta-analysis.经肛门局部切除直肠肿瘤后是否应关闭直肠缺损?系统评价和荟萃分析。
Tech Coloproctol. 2017 Dec;21(12):929-936. doi: 10.1007/s10151-017-1714-9. Epub 2017 Nov 13.
9
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.直肠癌的器官保存(GRECCAR 2):一项前瞻性、随机、开放标签、多中心、3 期临床试验。
Lancet. 2017 Jul 29;390(10093):469-479. doi: 10.1016/S0140-6736(17)31056-5. Epub 2017 Jun 7.
10
Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.直肠癌新辅助放化疗及经肛门内镜显微手术后的磁共振成像
Colorectal Dis. 2017 Jun;19(6):O196-O203. doi: 10.1111/codi.13691.